Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Scientific reports·2023
Same author

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019
Same author

Targeted delivery of antisense oligonucleotides to pancreatic β-cells.

Science advances·2018
Same author

Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia.

Blood cancer journal·2017
Same author

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia.

Leukemia·2017
Same author

Inhibition of Cell Growth by Antisense Oligonucleotides Targeting the Growth-Related Protein Kinase c-raf.

Methods in molecular medicine·2011
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
Same journal

Which HTT transcript to lower?

Trends in pharmacological sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.9K

Elucidating cell signaling mechanisms using antisense technology.

E Koller1, W A Gaarde, B P Monia

  • 1Department of Molecular and Cellular Pharmacology, Isis Pharmaceuticals, Carlsbad, CA 92008, USA. ekoller@isisph.com

Trends in Pharmacological Sciences
|March 31, 2000
PubMed
Summary
This summary is machine-generated.

Antisense oligonucleotides offer a specific and versatile new method for studying cell signaling pathways. This approach aids in understanding diseases and developing targeted drugs for better treatment outcomes.

More Related Videos

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.4K
Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
11:57

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

7.0K

Related Experiment Videos

Last Updated: Jan 13, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.9K
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.4K
Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
11:57

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

7.0K

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Pharmacology

Background:

  • Cellular signaling defects underlie many human diseases.
  • Understanding signal transduction is key for effective drug discovery.
  • Traditional methods for studying cell signaling have limitations.

Purpose of the Study:

  • To review the utility of antisense oligonucleotides (ASOs) in studying cell signal transduction.
  • To highlight ASOs as a tool for identifying pathway inhibitors for drug development.

Main Methods:

  • Review of existing literature on antisense oligonucleotide applications in cell signaling research.
  • Analysis of the specificity and versatility of ASOs in probing signal transduction pathways.

Main Results:

  • ASOs provide a highly specific and versatile method for investigating cell signaling.
  • This technique facilitates the study of complex signal transduction mechanisms.
  • ASOs enable the identification of potential drug targets within signaling pathways.

Conclusions:

  • Antisense oligonucleotides represent a powerful tool for advancing the study of cell signaling.
  • Their application can accelerate the discovery of novel therapeutics for various diseases.
  • ASOs offer significant advantages over traditional methods in drug development research.